Agree with most everything but PIQ do need to demonstrate that they have the ability to commercialise and make profitable the Promarker D test.
Bio-techs and Pharma must demonstrate they have the business acumen to successfully create revenue from their own products. You would have noticed those that have current products on the market demonstrating cashflow have a much stronger MC. Big Pharma are looking for easy scale-ability for a market ready product that can demonstrate some sales history, because if you look at PIQ selling $1m of Promarker D tests by 2 sales consultants in 2 markets, Big Pharma extrapolate that into " we have 4000, sales people in 74 countries" $$$
so as far as I see my investment in PIQ they must demonstrate the ability to apply Business acumen to their science...do I think they will be successful ,,Yes,, they seem to be achieving their current strategy on track,,on time.. can't wait to hear what the next country or territory is our next licensee..
PIQ Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)